A naukri.com initiative
Bioengineer
3d
80
Image Credit: Bioengineer
Sarcopenia Risks in Gastric Cancer Patients
- A meta-analysis in BMC Cancer revealed insights into sarcopenia prevalence and risk factors among gastric cancer patients, with an incidence rate of approximately 26.6%.
- Sarcopenia is a clinically relevant condition affecting gastric cancer patients, impacting chemotherapy tolerance, recovery, and survival rates.
- Age, gender, BMI, and nutritional risk screening scores were identified as significant risk factors for sarcopenia in gastric cancer patients.
- Nutritional interventions for high-risk patients, geriatric assessments, and personalized management strategies could mitigate sarcopenic progression.
- Tumor characteristics like size play a role in sarcopenia development, while other clinical parameters may not independently predict muscle depletion.
- The complex pathophysiology of sarcopenia in gastric cancer involves chronic inflammation, reduced nutrient absorption, and decreased physical activity.
- Standardized diagnostic criteria for sarcopenia in oncologic settings are essential for research comparability and therapeutic targeting.
- Findings highlight the need for proactive strategies, precision medicine approaches, and emerging therapies to address sarcopenia in gastric cancer comprehensively.
- The study emphasizes a multidisciplinary approach integrating oncology, nutrition, and rehabilitation to tackle the muscle depletion syndrome effectively.
- Regional disease patterns, cultural, dietary, and genetic factors influence sarcopenia risk, indicating the importance of tailored strategies.
Read Full Article
4 Likes
For uninterrupted reading, download the app